Analysis of pseudouridines and other RNA modifications using HydraPsiSeq protocol.
Deep sequencing
Epitranscriptome
Pseudouridylation
RNA modification
Regulation
Journal
Methods (San Diego, Calif.)
ISSN: 1095-9130
Titre abrégé: Methods
Pays: United States
ID NLM: 9426302
Informations de publication
Date de publication:
07 2022
07 2022
Historique:
received:
16
07
2021
revised:
27
08
2021
accepted:
29
08
2021
pubmed:
5
9
2021
medline:
22
6
2022
entrez:
4
9
2021
Statut:
ppublish
Résumé
Detection of RNA modified nucleotides using deep sequencing can be performed by several approaches, including antibody-driven enrichment and natural or chemically induced RT signatures. However, only very few RNA modified nucleotides generate natural RT signatures and antibody-driven enrichment heavily depends on the quality of antibodies used and may be highly biased. Thus, the use of chemically-induced RT signatures is now considered as the most trusted experimental approach. In addition, the use of chemical reagents allows inclusion of simple "mock-treated" controls, to exclude spontaneous RT arrests, SNPs and other misincorporation-prone sites. Hydrazine is a well-known RNA-specific reagent, already extensively used in the past for RNA sequencing and structural probing. Hydrazine is highly reactive to U and shows low reaction rates with ψ residues, allowing their distinction by deep sequencing-based protocols. However, other modified RNA residues also show particular behavior upon hydrazine treatment. Here we present methodological developments allowing to use HydraPsiSeq for precise quantification of RNA pseudouridylation and also detection and quantification of some other RNA modifications, in addition to ψ residues.
Identifiants
pubmed: 34481083
pii: S1046-2023(21)00206-1
doi: 10.1016/j.ymeth.2021.08.008
pii:
doi:
Substances chimiques
Hydrazines
0
Nucleotides
0
Pseudouridine
1445-07-4
RNA
63231-63-0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
383-391Informations de copyright
Copyright © 2021 Elsevier Inc. All rights reserved.